Insights

Celiac disease, a chronic intestinal disorder, was first identified in the late 19th century. Its link to gluten intolerance was established in 1950, leading to its recognition as gluten enteropathy.

Area of Science:

  • Gastroenterology
  • Pediatrics
  • Clinical Medicine

Context:

  • Celiac disease has a history spanning over a century, initially observed as a growth and malabsorption syndrome in children.
  • Early descriptions by Gee and Herter focused on enteropathies, with the large intestine mistakenly implicated.
  • The critical role of gluten in chronic intestinal disease was first identified by Dutch pediatrician W. Dicke in 1950.

Purpose:

  • To provide a historical overview of the understanding and naming of celiac disease.
  • To highlight key milestones in the identification of its etiology and associated symptoms.
  • To establish the etymological connections and synonyms for celiac affection.

Summary:

  • Celiac disease was first described in 1888 by S. Gee, who noted growth inhibition and malabsorption in children.
  • Initially termed 'celiac affection,' the condition was later described as 'intestinal infantilism' by C. Herter.
  • W. Dicke's 1950 discovery linked gluten intolerance to chronic childhood intestinal disease, leading to synonyms like gluten enteropathy.

Impact:

  • Recognizing gluten as the causative agent revolutionized the understanding and management of celiac disease.
  • The historical progression of its description underscores the evolution of clinical observation and diagnostic capabilities.
  • Synonyms like gluten intolerance and non-tropical sprue reflect the diverse historical perspectives on this condition.

Related Concept Videos

Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes: